Syntactx offers expertise and precision in adverse event coding

March 5, 2020

Adverse events that occur in clinical trials must be categorized in a uniform manner to allow standardization among patients, investigations sites, and studies. Medical coders rely on a standardized coding platform with unambiguous rules for classification to streamline the process by which such terms are uniformly assigned and recorded. MedDRA has been the gold-standard for adverse event classification for over two decades.

Syntactx now has six Certified MedDRA coders, each of whom has passed the certification examination. 

Syntactx performs coding of adverse events using MedDRA terminology and certified MedDRA coders.

MedDRA Coding Background

MedDRA coding is considered today’s gold standard in clinical trial management. MedDRA was developed in the 1990s after the research community identified a need for standardized and granular terminology for regulatory agencies and industry alike. Prior paradigms such as COSTART, WHO-ART, J-ART, H-ARTS, ICD-9 and ICD-9CM were updated so infrequently that users created their own versions and standardization was lost.  

The Syntactx Promise

The use of MedDRA Coding in how we conduct the management of clinical trials is one of many examples of how we’ve built our firm around the highest professional standards. Our commitment to these standards is articulated in the Syntactx Promise, a set of principles that guides everything we do: expertise, quality, transparency, precision, and performance.